Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviors indicative of anxiety
- PMID: 1775600
Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviors indicative of anxiety
Abstract
The present investigation was a pilot study to determine whether a single dose of mianserin, which produces long-term down-regulation of serotonin1C (5-HT1c) and 5-HT2 receptors, would prevent anxiogenic behaviors occurring during ethanol withdrawal as evaluated in the elevated plus maze. Male Long-Evans hooded rats were fed a liquid diet containing 4.5 percent ethanol for 4 days. Mianserin (20 mg/kg, i.p.) was injected on the morning of the third day of ethanol administration, or 48 hrs and 7 days prior to testing. When animals were tested either 12 hrs (acute withdrawal) or 5 days (protracted withdrawal) after the last dose of ethanol, anxiogenic behaviors were observed as a significant reduction in both percentage of open-arm entries and time spent on the open arms. In contrast, these anxiogenic behaviors were prevented by pre-injection with mianserin 48 hrs or 7 days prior to testing. Attenuation of this important symptom of ethanol withdrawal is of particular importance because, in addition to the nonaddicting properties of mianserin relative to current anxiolytics, the beneficial effects appear to be long lasting and can be achieved with a single dose.
Similar articles
-
Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.Peptides. 2009 Jun;30(6):1165-72. doi: 10.1016/j.peptides.2009.02.002. Epub 2009 Feb 12. Peptides. 2009. PMID: 19463751
-
Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety.J Pharmacol Exp Ther. 1999 Feb;288(2):866-78. J Pharmacol Exp Ther. 1999. PMID: 9918601
-
Attenuation of benzodiazepine withdrawal anxiety in the rat by serotonin antagonists.Behav Brain Res. 2005 Jun 20;161(2):286-90. doi: 10.1016/j.bbr.2005.02.027. Epub 2005 Mar 31. Behav Brain Res. 2005. PMID: 15922055
-
Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.Alcohol Clin Exp Res. 2002 Oct;26(10):1494-501. doi: 10.1097/01.ALC.0000033120.51856.F0. Alcohol Clin Exp Res. 2002. PMID: 12394282
-
Anxiety-like behaviors following chronic ethanol exposure.Neurosci Biobehav Rev. 2005 Jan;28(8):837-50. doi: 10.1016/j.neubiorev.2004.11.001. Epub 2004 Dec 10. Neurosci Biobehav Rev. 2005. PMID: 15642625 Review.
Cited by
-
Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.Psychopharmacology (Berl). 1993;113(1):131-6. doi: 10.1007/BF02244345. Psychopharmacology (Berl). 1993. PMID: 7862819
-
Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene.J Neurosci. 2002 May 1;22(9):3730-8. doi: 10.1523/JNEUROSCI.22-09-03730.2002. J Neurosci. 2002. PMID: 11978849 Free PMC article.
-
SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats.Alcohol. 2004 Feb;32(2):101-11. doi: 10.1016/j.alcohol.2003.08.007. Alcohol. 2004. PMID: 15163561 Free PMC article.